Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1973-06-19
1976-01-20
Padgett, Benjamin R.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
424 95, 424177, A61K 4300, A61K 3516, A61K 3702
Patent
active
039339963
ABSTRACT:
The stability of fibrinogen is improved by mixing it with albumin, preferably at least 5 parts by weight of albumin per part by weight of fibrinogen. By this invention, iodinated (.sup.125 I) human fibrinogen can be stabilised with human serum albumin for use in the diagnosis of thrombi.
REFERENCES:
patent: 2085391 (1937-06-01), Reichel
patent: 3674900 (1972-07-01), Thompson
patent: 3784453 (1974-01-01), Dworkin et al.
patent: 3803299 (1974-04-01), Novel
Harrow, B., Textbook of Biochemistry, 5th Ed., Philadelphia, W. B. Saunders Co., 1950, p. 406.
Charlton John Cecil
Gravett David Lawrence
Nucker Christine M.
Padgett Benjamin R.
The Radiochemical Centre Limited
LandOfFree
Composition comprising radioactive labeled-fibrinogen and albumi does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Composition comprising radioactive labeled-fibrinogen and albumi, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition comprising radioactive labeled-fibrinogen and albumi will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1698620